AVAX Technologies Inc. (Kansas City, MO) and the University of Tokyo have entered into a collaborative research agreement to evaluate the application of the AVAX's patented AC Vaccine technology for the treatment of breast cancer...
Original Article: University of Tokyo to Evaluate AVAX's Breast Cancer Vaccine